BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34556492)

  • 1. Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID).
    Wild JM; Porter JC; Molyneaux PL; George PM; Stewart I; Allen RJ; Aul R; Baillie JK; Barratt SL; Beirne P; Bianchi SM; Blaikley JF; Brooke J; Chaudhuri N; Collier G; Denneny EK; Docherty A; Fabbri L; Gibbons MA; Gleeson FV; Gooptu B; Hall IP; Hanley NA; Heightman M; Hillman TE; Johnson SR; Jones MG; Khan F; Lawson R; Mehta P; Mitchell JA; Platé M; Poinasamy K; Quint JK; Rivera-Ortega P; Semple M; Simpson AJ; Smith D; Spears M; Spencer LG; Stanel SC; Thickett DR; Thompson AAR; Walsh SL; Weatherley ND; Weeks ME; Wootton DG; Brightling CE; Chambers RC; Ho LP; Jacob J; Piper Hanley K; Wain LV; Jenkins RG
    BMJ Open Respir Res; 2021 Sep; 8(1):. PubMed ID: 34556492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.
    Drake TM; Docherty AB; Harrison EM; Quint JK; Adamali H; Agnew S; Babu S; Barber CM; Barratt S; Bendstrup E; Bianchi S; Villegas DC; Chaudhuri N; Chua F; Coker R; Chang W; Crawshaw A; Crowley LE; Dosanjh D; Fiddler CA; Forrest IA; George PM; Gibbons MA; Groom K; Haney S; Hart SP; Heiden E; Henry M; Ho LP; Hoyles RK; Hutchinson J; Hurley K; Jones M; Jones S; Kokosi M; Kreuter M; MacKay LS; Mahendran S; Margaritopoulos G; Molina-Molina M; Molyneaux PL; O'Brien A; O'Reilly K; Packham A; Parfrey H; Poletti V; Porter JC; Renzoni E; Rivera-Ortega P; Russell AM; Saini G; Spencer LG; Stella GM; Stone H; Sturney S; Thickett D; Thillai M; Wallis T; Ward K; Wells AU; West A; Wickremasinghe M; Woodhead F; Hearson G; Howard L; Baillie JK; Openshaw PJM; Semple MG; Stewart I; Jenkins RG;
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1656-1665. PubMed ID: 33007173
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease.
    Fesu D; Polivka L; Barczi E; Foldesi M; Horvath G; Hidvegi E; Bohacs A; Muller V
    Inflammopharmacology; 2023 Apr; 31(2):565-571. PubMed ID: 36961666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Delphi consensus statement for the management of post-COVID interstitial lung disease.
    Hadda V; Suri TM; Iyer H; Jain A; Mittal S; Madan K; Mohan A; Seith Bhalla A; Sindhwani G; Dutt N; Venkatnarayan K; Nath A; Dhooria S; Kumar R; Marwah V; Karmakar S; Chaudhry D; Ayub II; Dwivedi DP; Tiwari P; Koul P; Behera AK; Saxena P; Sengupta A; Mohapatra PR; Goyal A; Christopher DJ; Guleria R
    Expert Rev Respir Med; 2022 Sep; 16(9):983-995. PubMed ID: 36154545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.
    Myall KJ; Mukherjee B; Castanheira AM; Lam JL; Benedetti G; Mak SM; Preston R; Thillai M; Dewar A; Molyneaux PL; West AG
    Ann Am Thorac Soc; 2021 May; 18(5):799-806. PubMed ID: 33433263
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease.
    Johnston J; Dorrian D; Linden D; Stanel SC; Rivera-Ortega P; Chaudhuri N
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
    Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
    Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease.
    Ohgushi M; Ogo N; Yanagihara T; Harada Y; Sumida K; Egashira A; Asoh T; Maeyama T; Yoshizawa S
    Intern Med; 2022 Feb; 61(4):585-589. PubMed ID: 34866097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-COVID Interstitial Lung Disease - The Looming Epidemic.
    Singh AK; Kumar OP; Bansal P; Margekar SL; Aggarwal R; Ghotekar LR; Gupta A
    J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic.
    Guiot J; Henket M; Frix AN; Delvaux M; Denis A; Giltay L; Thys M; Gester F; Moutschen M; Corhay JL; Louis R;
    Respir Investig; 2020 Nov; 58(6):437-439. PubMed ID: 32978099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and intrasubject variation in the respiratory microbiome in interstitial lung disease.
    Cho JY; Kim MY; Kim JH; Kim EG; Kim SH; Yang B; Kang H; Lee KM; Choe KH; Shin YM
    Medicine (Baltimore); 2023 Apr; 102(14):e33402. PubMed ID: 37026952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study.
    Miyashita K; Hozumi H; Furuhashi K; Nakatani E; Inoue Y; Yasui H; Suzuki Y; Karayama M; Enomoto N; Fujisawa T; Inui N; Ojima T; Suda T
    Respir Res; 2024 Feb; 25(1):95. PubMed ID: 38383463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
    Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
    Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol.
    Sigfrid L; Cevik M; Jesudason E; Lim WS; Rello J; Amuasi J; Bozza F; Palmieri C; Munblit D; Holter JC; Kildal AB; Reyes LF; Russell CD; Ho A; Turtle L; Drake TM; Beltrame A; Hann K; Bangura IR; Fowler R; Lakoh S; Berry C; Lowe DJ; McPeake J; Hashmi M; Dyrhol-Riise AM; Donohue C; Plotkin D; Hardwick H; Elkheir N; Lone NI; Docherty A; Harrison E; Baille JK; Carson G; Semple MG; Scott JT
    BMJ Open; 2021 Mar; 11(3):e043887. PubMed ID: 33692181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data.
    Vaeli Zadeh A; Dinparastisaleh R; Vaezi A; Bandyopadhyay D; Rubinstein I; Baig HZ; Calderon-Candelario R; Hashemi Shahraki A; Kawasaki T; Magnusson JM; Larsson LO; Sharafkhaneh A; Herazo-Maya JD; Lee AS; Mirsaeidi M
    Ann Am Thorac Soc; 2024 Mar; 21(3):428-437. PubMed ID: 38134434
    [No Abstract]   [Full Text] [Related]  

  • 17. Rheumatoid interstitial lung disease in Canterbury New Zealand: prevalence, risk factors and long-term outcomes-protocol for a population-based retrospective study.
    Farquhar H; Beckert L; Edwards A; Matteson EL; Thiessen R; Ganly E; Stamp LK
    BMJ Open; 2022 Apr; 12(4):e050934. PubMed ID: 35383056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and acute exacerbation of interstitial lung disease.
    Kondoh Y; Kataoka K; Ando M; Awaya Y; Ichikado K; Kataoka M; Komase Y; Mineshita M; Ohno Y; Okamoto H; Ooki T; Tasaka Y; Tomioka H; Suda T
    Respir Investig; 2021 Sep; 59(5):675-678. PubMed ID: 34272158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).
    Gagiannis D; Steinestel J; Hackenbroch C; Schreiner B; Hannemann M; Bloch W; Umathum VG; Gebauer N; Rother C; Stahl M; Witte HM; Steinestel K
    Front Immunol; 2020; 11():587517. PubMed ID: 33123171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental and quantitative imaging techniques in interstitial lung disease.
    Weatherley ND; Eaden JA; Stewart NJ; Bartholmai BJ; Swift AJ; Bianchi SM; Wild JM
    Thorax; 2019 Jun; 74(6):611-619. PubMed ID: 30886067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.